Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane and Carboplatin for Advanced NSCLC
NCT00729612Phase 2Completed
- Start
- Aug 2008
- Primary completion
- Dec 2011
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in non-small cell lung cancer (NSCLC). Started Aug 2008; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00729612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729612.